Stay updated on Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was reformatted. The recruitment status now indicates No longer looking for participants, with updates to the study citation and revision metadata.SummaryDifference0.2%

- Check20 days agoChange DetectedA new page revision tag was added (v3.5.5), signaling a back-end update to the ClinicalTrials.gov page; the study details and user-facing content remain unchanged.SummaryDifference0.0%

- Check41 days agoChange DetectedA new publication citation for the HIMALAYA five-year survival update was added, and the page revision tag updated from v3.5.3 to v3.5.4.SummaryDifference0.0%

- Check48 days agoChange DetectedThe Taiwan recruitment locations were updated: Taoyuan District, Taiwan was removed and Taoyuan, Taiwan was added.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page’s displayed site/version label has been updated from Revision v3.5.2 to Revision v3.5.3, indicating a minor update to the ClinicalTrials.gov site itself rather than any change to the study record.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.